13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000919574-23-003259
Total Value
$39.6M
Positions
15
Other Managers
0
Confidential Omitted
Yes
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAVARA INC | SVRA | 6,896,551 | $13.4M | 33.97% |
| 2 | XERIS BIOPHARMA HOLDINGS INC | XERS | 6,039,028 | $9.8M | 24.86% |
| 3 | SPDR S&P 500 ETF TR | SPY | 15,947 | $6.5M | 16.49% |
| 4 | REZOLUTE INC | RZLT | 1,403,157 | $2.7M | 6.80% |
| 5 | SPDR SER TR | 78468R556 | 17,500 | $2.2M | 5.64% |
| 6 | VECTIVBIO HLDG AG | H9060V101 | 156,651 | $1.3M | 3.40% |
| 7 | ALPS ETF TR | 00162Q452 | 29,500 | $1.1M | 2.88% |
| 8 | MOLECULAR TEMPLATES INC | 608550109 | 2,052,991 | $779,931 | 1.97% |
| 9 | COMPASS THERAPEUTICS INC | CMPX | 211,740 | $675,451 | 1.71% |
| 10 | ALLAKOS INC | 01671P100 | 86,533 | $385,073 | 0.97% |
| 11 | CABALETTA BIO INC | CABA | 40,581 | $335,602 | 0.85% |
| 12 | ELEVATION ONCOLOGY INC | 28623U101 | 68,324 | $129,815 | 0.33% |
| 13 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 21,333 | $40,533 | 0.10% |
| 14 | BRIDGETOWN HOLDINGS LTD | G1355U121 | 39,773 | $6,970 | 0.02% |
| 15 | LANVIN GROUP HOLDINGS LIMITE | LANV-WT | 12,000 | $4,500 | 0.01% |